Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile

BACKGROUND: The clinical outcomes and cost implications of a diagnostic shift from an EIA- to PCR-based assay for Clostridium difficile infection (CDI) have not been completely described in the literature. METHODS: The impact of the PCR-based assay on the incidence and duration of CDI therapy was co...

Descripción completa

Detalles Bibliográficos
Autores principales: Guinta, Margaret M., Bunnell, Kristen, Harrington, Amanda, Bleasdale, Susan, Danziger, Larry, Wenzler, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713042/
https://www.ncbi.nlm.nih.gov/pubmed/29202797
http://dx.doi.org/10.1186/s12941-017-0252-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713042/
https://www.ncbi.nlm.nih.gov/pubmed/29202797
http://dx.doi.org/10.1186/s12941-017-0252-7

Ejemplares similares